Grifols GRFS
NASDAQ GRFS
$8.00 +0.01 (+0.13%)
At close: Aug 21, 2026 · 4:00 PM EDT

Grifols (GRFS) Cost of Revenue (2010 - 2020)

Grifols' (GRFS) quarterly Cost of Revenue came in at $775.1 million in Q1 2020, up 8.46% YoY from $714.6 million in Q2 2019, and down 65.08% on a QoQ basis from $2.2 billion in Q4 2019.

Grifols (GRFS) Cost of Revenue (2010 - 2020) Analysis & Trends

Grifols (GRFS) has 11 years of Cost of Revenue data on file, last reported at $775.1 million in Q1 2020.

  • Quarterly Cost of Revenue rose 8.46% year-over-year to $775.1 million in Q1 2020, while the trailing twelve-month figure through Mar 2020 was $5.7 billion (up 40.75% YoY) and the FY2025 annual result came in at $5.4 billion, up 15.02% from the prior year.
  • Cost of Revenue fell to $775.1 million in Q1 2020, from $2.2 billion in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $2.2 billion in Q4 2019 to a low of $553.8 million in Q1 2017.
  • A 5-year average of $995.6 million and a median of $674.0 million in 2018 frame the typical range for Cost of Revenue.
  • Annual changes were most pronounced in 2016 — Cost of Revenue climbed 3.94% — and 2017, when it surged 195.8%.
  • Tracing GRFS's Cost of Revenue over 5 years: stood at $643.1 million in 2016, then jumped by 195.8% to $1.9 billion in 2017, then advanced by 3.94% to $2.0 billion in 2018, then rose by 12.25% to $2.2 billion in 2019, then sank by 65.08% to $775.1 million in 2020.
  • The last three Cost of Revenue figures came in at $775.1 million (Q1 2020), $2.2 billion (Q4 2019), and $714.6 million (Q1 2019), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Johnson & Johnson 652.20 Bn 631.44 Bn 17.26 Bn 8.05 Bn
2 AbbVie 469.51 Bn 462.94 Bn 12.70 Bn 4.29 Bn
3 Merck 376.81 Bn 369.67 Bn 12.21 Bn 4.40 Bn
4 Novartis Ag 303.04 Bn 295.35 Bn 11.24 Bn 3.71 Bn
5 Astrazeneca 257.61 Bn 252.71 Bn 12.86 Bn 2.52 Bn
6 Amgen 237.37 Bn 223.38 Bn 7.24 Bn 2.81 Bn
7 Gilead Sciences 181.73 Bn 178.55 Bn 6.22 Bn 1.58 Bn
8 Pfizer 159.66 Bn 147.96 Bn 10.94 Bn 4.09 Bn
9 Gsk 106.24 Bn 102.07 Bn 8.24 Bn 3.04 Bn
10 Grifols 5.45 Bn 4.45 Bn - -

Historic Data

Download Data
DateValue
Mar 31, 2020 775.06 Mn
Mar 31, 2020 775.06 Mn
Dec 31, 2019 2.22 Bn
Dec 31, 2019 2.22 Bn
Mar 31, 2019 714.63 Mn
Mar 31, 2019 714.63 Mn
Dec 31, 2018 1.98 Bn
Dec 31, 2018 1.98 Bn
Jun 30, 2018 691.82 Mn
Jun 30, 2018 691.82 Mn
Mar 31, 2018 656.26 Mn
Mar 31, 2018 656.26 Mn
Dec 31, 2017 1.90 Bn
Dec 31, 2017 1.90 Bn
Jun 30, 2017 626.15 Mn
Jun 30, 2017 626.15 Mn
Mar 31, 2017 553.78 Mn
Mar 31, 2017 553.78 Mn
Dec 31, 2016 643.10 Mn
Dec 31, 2016 643.10 Mn